Tempest Therapeutics, Inc. Marketable Securities
Tempest Therapeutics, Inc. (TPST) had Marketable Securities of $439.00 thousand as of 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2021-05-13
- 2021-03-31: Marketable Securities $439.00K.
- 2020-12-31: Marketable Securities $0.00.
- 2019-12-31: Marketable Securities $0.00.
- 2019-03-31: Marketable Securities $1.40M.
| Period end | Marketable Securities |
|---|---|
| 2021-03-31 | $439.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $0.00 10-Q · filed 2021-05-13 |
| 2019-12-31 | $0.00 10-K · filed 2020-03-11 |
| 2019-03-31 | $1.40M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $4.38M 10-K · filed 2020-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |